| PERFICIENT PHARM LTD |
| Registered number: |
15155847 |
| Balance Sheet |
AMENDED |
| as at 30 September 2025 |
|
| Notes |
|
|
2025 |
|
| £ |
|
| Current assets |
| Debtors |
3 |
|
25,719 |
| Cash at bank and in hand |
|
|
61,144 |
|
|
|
86,863 |
|
|
|
| Creditors: amounts falling due within one year |
4 |
|
(123,786) |
|
| Net current (liabilities)/assets |
|
|
|
(36,923) |
|
|
| Net (liabilities)/assets |
|
|
|
(36,923) |
|
|
|
|
|
|
|
| Capital and reserves |
| Called up share capital |
|
|
|
100 |
| Profit and loss account |
|
|
|
(37,023) |
|
| Shareholders' funds |
|
|
|
(36,923) |
|
|
|
|
|
|
|
| The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006. |
| The members have not required the company to obtain an audit in accordance with section 476 of the Act. |
| The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. |
| The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies. |
|
|
|
|
| Hussein Ahmed Sayeed Patel |
| Director |
| Approved by the board on 26 October 2026 |
|
| PERFICIENT PHARM LTD |
| Notes to the Accounts |
| for the year ended 30 September 2025 |
|
|
| 1 |
Accounting policies |
|
|
Basis of preparation |
|
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard). |
|
|
Turnover |
|
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. |
|
|
| 2 |
Employees |
2025 |
|
| Number |
|
|
|
Average number of persons employed by the company |
2 |
|
|
|
|
|
|
|
|
|
| 3 |
Debtors |
2025 |
|
| £ |
|
|
|
VAT refund |
|
13,969 |
|
Other debtors |
11,750 |
|
|
|
|
|
|
25,719 |
|
|
|
|
|
|
|
|
|
|
| 4 |
Creditors: amounts falling due within one year |
2025 |
|
| £ |
|
|
|
Trade creditors |
15,733 |
|
Director loan |
|
62,411 |
|
Taxation and social security costs |
231 |
|
Other creditors |
45,411 |
|
|
|
|
|
|
123,786 |
|
|
|
|
|
|
|
|
|
|
| 5 |
Other information |
|
|
PERFICIENT PHARM LTD is a private company limited by shares and incorporated in England. Its registered office is: |
|
1 Falklands House |
|
Black Bourton Road |
|
Oxfordshire |
|
Carterton |
|
OX18 3DN |